tiprankstipranks
Trending News
More News >
Diagnos (TSE:ADK)
:ADK
Canadian Market

Diagnos (ADK) Price & Analysis

Compare
21 Followers

ADK Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.50%0.29%97.21%
Mutual Funds
0.29% Other Institutional Investors
97.21% Public Companies and
Individual Investors

ADK FAQ

What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.43 in the past 12 months.
    What is Diagnos’s market cap?
    Diagnos’s market cap is C$20.37M.
      When is Diagnos’s upcoming earnings report date?
      Diagnos’s upcoming earnings report date is Aug 21, 2025 which is in 70 days.
        How were Diagnos’s earnings last quarter?
        Diagnos released its earnings results on May 28, 2025. The company reported -C$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.013.
          Is Diagnos overvalued?
          According to Wall Street analysts Diagnos’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Diagnos pay dividends?
            Diagnos does not currently pay dividends.
            What is Diagnos’s EPS estimate?
            Diagnos’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Diagnos have?
            Diagnos has 101,862,976 shares outstanding.
              What happened to Diagnos’s price movement after its last earnings report?
              Diagnos reported an EPS of -C$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
                Which hedge fund is a major shareholder of Diagnos?
                Currently, no hedge funds are holding shares in TSE:ADK

                Diagnos Stock Smart Score

                Company Description

                Diagnos

                DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
                Similar Stocks
                Company
                Price & Change
                Follow
                Aiml Resources
                Treatment.com International
                Telecure Technologies Inc
                Comprehensive Healthcare Systems Inc
                UniDoc Health Corp
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis